What’s New in Diagnostic Technologies for People Living with Blood Cancers

Peter Martin, MD, MS

Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

William I. Bensinger, MD

Center for Blood Disorders and Stem Cell Transplantation, SCI’s Personalized Medicine Program, Myeloma & Transplant Program, Swedish Cancer Institute

Ruben A. Mesa, MD, FACP

Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, UT Health San Antonio Cancer Center – An NCI Designated Cancer Center

Elizabeth K. O’Donnell, MD

Director, Lifestyle Clinic, Massachusetts General Hospital, Associate Director, Mass General Cancer Center’s Survivorship Program, Assistant Professor of Medicine, Harvard Medical School

Joseph Khoury, MD, FCAP

Professor, Division of Pathology & Lab Medicine, Department of Hematopathology, Medical Director, Clinical Expansion, Division of Pathology & Lab Medicine, Executive Director, MD Anderson Cancer Network, Division of Pathology & Lab Medicine, The University of Texas M. D. Anderson Cancer Center

Sarah Thibault-Sennett, PhD

Senior Manager of Public Policy and Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare